中文

KBA

KraneShares Bosera MSCI China A Share ETF

Deal or No Deal? Trade War Scenario Analysis and Economic Outlook

Download Fact Sheet

Investment Strategy:

KBA is benchmarked to the MSCI China A Index which captures large and mid-cap representation across China securities listed on the Shanghai and Shenzhen exchanges (A-shares). Over the coming years, MSCI will complete the incremental inclusion of China A-shares into their Global Standard Indexes, including the MSCI Emerging Markets Index, which may potentially benefit the securities KBA holds today. The MSCI China A Index is designed for global investors accessing the A-share market using the Stock Connect framework and is calculated using China A Stock Connect listings based on the offshore RMB exchange rate (CNH).

KBA features:

  • Access to the Shanghai and Shenzhen Stock Exchanges - historically unavailable to U.S. investors - via Stock Connect Programs.
  • KBA's benchmark, The MSCI China A Index, reflects a 20% inclusion factor for China A large-cap, mid-cap, and eligible ChiNext shares within the MSCI Emerging Markets Index.
  • With over $1.8 trillion1 benchmarked to the MSCI Emerging Markets Index, full inclusion of Mainland Chinese equities could see significant flows into the securities KBA owns today.
  • Co-managed by Bosera Asset Management; headquartered in Shenzhen, over $127 billion in AUM, one of the largest Chinese asset managers by assets.2

1.) As of June 30, 2018, as reported on September 30, 2018 by eVestment, Morningstar and Bloomberg.

2.) Bosera data is from bosera.com as of 12/31/2018, retrieved on 3/31/2019.

Fund Details

Data as of 09/13/2019
TickerKBA
Primary ExchangeNYSE
CUSIP500767405
ISINUS5007674055
Net Assets$600,419,570
Total Annual Fund Operating Expense (Gross)0.80%
Total Annual Fund Operating Expense (Net)0.60%*
Inception Date3/4/2014
Distribution FrequencyAnnual

Fund Documents

Daily Performance

Data as of 09/13/2019
Premium Discount Chart
NAV
Net Asset Value$31.68 
Daily Change0.60%
Price
Closing Price$31.87 
Daily Change0.66%

Performance History

Distributions
Cumulative %
Data as of: 08/31/2019		Fund NAVClosing PriceIndex
1 Month-3.83%-2.86%-3.66%
3 Month2.65%3.00%2.98%
6 Month-1.90%-2.03%-1.36%
Since Inception40.64%41.00%49.24%
Avg Annualized %
Data as of month end: 08/31/2019		Fund NAVClosing PriceIndex
1 Year10.99% 11.81%11.78%
3 Year2.68%2.49%1.53%
5 Year5.18%5.11%6.48%
Since Inception6.41% 6.46%7.56%
Avg Annualized %
Data as of quarter end: 06/30/2019		Fund NAVClosing PriceIndex
1 Year6.72%7.58%7.20%
3 Year5.94%6.14%4.62%
5 Year8.03%7.96%9.34%
Since Inception7.30% 7.39%8.43%

*Pursuant to the terms of an Expense Limitation Agreement, Krane Funds Advisors, LLC (“Krane”), the Fund’s investment manager, has contractually agreed to reduce its management fee to 0.58% of the Fund’s average daily net assets until August 1, 2020. The Expense Limitation Agreement may only be terminated prior to August 1, 2020 by the Board.

The Hybrid KBA Index consists of the MSCI China A Index from the inception of the Fund through October 23, 2014, the MSCI China A International Index from October 23, 2014 through December 26, 2017 and the MSCI China A Inclusion Index from December 26, 2017 to May 29, 2019 and the MSCI China A Index going forward.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted.

Sector Breakdown

Data as of: 2019/9/13

Market Cap Breakdown

Data as of: 2019/9/13
Data provided by ETF Research Center

Top 10 Holdings

Data as of 09/13/2019
Full Holdings .CSV
RankCompany Name% of Net AssetsTickerShares HeldMarket Value($)
1
KWEICHOW MOUTAI CO LTD-A
5.17%600519 C1198,44831,009,704
2
PING AN INSURA-A
3.74%601318 C11,711,88122,475,877
3
CHINA MERCHANTS BANK-A
2.72%600036 C13,259,92916,357,352
4
WULIANGYE YIBIN CO LTD-A
1.91%000858 C2613,36811,472,688
5
CHINA YANGTZE-A
1.55%600900 C13,476,5679,317,838
6
INDUSTRIAL BANK CO LTD -A
1.39%601166 C13,282,8628,350,571
7
SHANG PUDONG-A
1.32%600000 C14,638,3717,914,071
8
JIANGSU HENGRU-A
1.3%600276 C1698,8687,810,357
9
HANGZHOU HIKVI-A
1.21%002415 C21,477,3517,246,962
10
IND & COMM BK OF CHINA-A
1.12%601398 C18,521,2266,748,550

Holdings are subject to change.

Related Content:

Topics

©2019 Krane Funds Advisors, LLC
1270 Ave of the Americas, Suite 2217, New York, NY 10020

Carefully consider the Funds' investment objectives, risk factors, charges and expenses before investing. This and additional information can be found in the Funds' full & summary prospectus, which may be obtained here: KWEB, KBA, OBOR, KGRN, KARS, KURE, KEMQ, KCNY, KFYP, KALL, KCCB, KMED, KEMX. Read the prospectus carefully before investing. Please note these links also contain the fund's current top ten holdings.

Investing involves risk, including possible loss of principal. There can be no assurance that a Fund will achieve its stated objectives. ETF shares are not redeemable with the issuing fund other than in large Creation Unit aggregations. Instead, investors must buy or sell ETF Shares in the secondary market with the assistance of a stockbroker. In doing so, the investor may incur brokerage commissions and may pay more than net asset value when buying and receive less than net asset value when selling. The NAV of the Fund’s shares is calculated each day the national securities exchanges are open for trading as of the close of regular trading on the New York Stock Exchange (“NYSE”), normally 4:00 p.m. Eastern time (the “NAV Calculation Time”). Shares are bought and sold at market price (closing price) not NAV. Market price returns are based on the midpoint of the bid/ask spread at 4:00 pm Eastern Time (when NAV is normally determined).

The Funds are subject to political, social or economic instability within China which may cause decline in value. Variable-interest entities (VIEs) do not give investors ownership in the operating company as stock does. The enforceability of the VIE structure is not guaranteed by Chinese law. Fluctuations in currency of foreign countries may have an adverse effect to domestic currency values. Emerging markets involve heightened risk related to the same factors as well as increase volatility and lower trading volume.

Narrowly focused investments typically exhibit higher volatility. Internet companies are subject to rapid changes in technology, worldwide competition, rapid obsolescence of products and services, loss of patent protections, evolving industry standards and frequent new product productions. Such changes may have an adverse impact on performance. Technology companies may be subject to severe competition and rapid obsolescence. The KraneShares CSI China Internet ETF, the KraneShares MSCI One Belt One Road ETF, the KraneShares CICC China Leaders 100 Index ETF, the KraneShares Emerging Markets Consumer Technology ETF, the KraneShares MSCI China Environment ETF, the KraneShares Electric Vehicles and Future Mobility Index ETF, the KraneShares MSCI All China Health Care Index ETF, the KraneShares CCBS China Corporate High Yield Bond USD Index ETF, and the KraneShares Emerging Market Healthcare Index ETF are non-diversified.

The ability of the KraneShares Bosera MSCI China A ETF, the KraneShares MSCI All China Index ETF, the KraneShares MSCI One Belt One Road ETF, the KraneShares Emerging Markets Consumer Technology ETF, the KraneShares Electric Vechicles and Future Mobility Index ETF, the KraneShares MSCI All China Health Care Index ETF, and the KraneShares Emerging Market Healthcare Index ETF to achieve their respective investment objectives is dependent, in part, on the continuous availability of A Shares and the ability to obtain, if necessary, additional A Shares quota. If a Fund is unable to obtain sufficient exposure to limited availability of A Share quota, the Fund could seek exposure to the component securities of the Underlying Index by investment in other types of securities. The funds may in invest in derivatives, which are often more volatile than other investments and may magnify the Funds’ gains or losses.

The KraneShares E Fund China Commercial Paper ETF & The KraneShares CCBS China Corporate High Yield Bond USD Index ETF are subject to interest rate risk, which is the chance that bonds will decline in value as interest rates rise. The components of the securities held by these Funds will be rated by Chinese credit rating agencies, which may use different criteria and methodology than U.S. entities or international credit rating agencies. The Fund may invest in high yield and unrated securities, whose prices are generally more sensitive to adverse economic changes and consequently more volatile. These Funds are subject to industry concentration risk and is non-diversified. Narrowly focused investments typically exhibit higher volatility.

The KraneShares CCBS China Corporate High Yield Bond USD Index ETF invests in perpetual bonds, which offer fixed return with no maturity date. Perpetual bonds can be more volatile than other types of bonds that have a maturity date and may be more sensitive to changes to interest rates.

The KraneShares CCBS China Corporate High Yield Bond USD Index ETF depends on the CIBM Program to invest directly in RMB Bonds. There is no guarantee the Fund will be able to continue to participate in the program.

The KraneShares MSCI All China Health Care Index ETF and the KraneShares Emerging Market Healthcare Index ETF invests primarily in the health care industry. The profitability of companies in the healthcare sector may be affected by government regulations and government healthcare programs, government reimbursement for medical expenses, increases or decreases in the cost of medical products and services, limited product lines, increased emphasis on the delivery of healthcare through outpatient services and product liability claims. Many healthcare companies are heavily dependent on patent protection, which may be time consuming and costly, and the expiration of a company’s patent may adversely affect that company’s profitability. Healthcare companies are subject to competitive forces that may result in pricing pressure, including price discounting, and may be thinly capitalized and susceptible to product obsolescence. Many new products in the healthcare sector require significant research and development and may be subject to regulatory approvals, which may be time consuming and costly and with no guarantee that the product will come to market.

Indices are unmanaged and do not include the effect of fees. One cannot invest directly in an index.

The KraneShares ETFs are distributed by SEI Investments Distribution Company (SIDCO), 1 Freedom Valley Drive, Oaks, PA 19456, which is not affiliated with Krane Funds Advisors, LLC, the Investment Adviser for the Fund.

Privacy Policy

You are now leaving KraneShares.com

Hyperlinks on this website are provided as a convenience and we disclaim any responsibility for information, services or products found on the websites linked hereto.

Click here to continue